ArticleJAAD international2026

Outcomes of brentuximab vedotin in cutaneous T-cell lymphoma: A Middle Eastern real-world study.

Ahmad Alsarraf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.